Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002-2011: A population-based cohort study

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Smolina, Kate ^a   Hanley, Gillian E ^a   Mintzes, Barbara ^a   Oberlander, Tim F ^b   Morgan, Steve ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BETA LACTAM ANTIBIOTIC; CODEINE; CONTRACEPTIVE AGENT; DOXYLAMINE PLUS PYRIDOXINE; FOLIC ACID; IRON; LEVOTHYROXINE SODIUM; MINERAL; OPIATE; PRESCRIPTION DRUG; RANITIDINE; VITAMIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CANADA; CHILD; COHORT ANALYSIS; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MEDICAL SERVICE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREGNANCY; PUERPERIUM; RETROSPECTIVE STUDY; SCHOOL CHILD; SMOKING; TREND STUDY; BRITISH COLUMBIA; FACTUAL DATABASE;

ADULT; BRITISH COLUMBIA; DATABASES, FACTUAL; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES;

EID: 84930197114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128312     Document Type: Article

References (48)

1. Lagoy CT, Joshi N, Cragan JD, Rasmussen SA. Report from the CDC: Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health. 2005; 14(2):104-9.
2. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol. 2002; 100(3):465-73. doi: Pii S0029-7844(02)02122-1 doi: 10.1016/S0029-7844(02)02122-1 PMID: ISI:000177691500011.
3. Adam MP, Polifka JE, Friedman J. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011; 157:175-82.
4. Parisi MA, Spong CY, Zajicek A, Guttmacher AE. We Don't Know What We Don't Study: The Case for Research on Medication Effects in Pregnancy. Am J Med Genet C Semin Med Genet. 2011; 157C (3):247-50. doi: 10.1002/Ajmg.C.30309 PMID: ISI:000293539100013.
5. Chan M, Sutcliffe A, Wong I. Prescription drug use in pregnancy: more evidence of safety is needed. The Obstetrician and Gynaecologist. 2012; 14:87-92.
6. Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011; 20(9):895-902. doi: 10.1002/pds.2184 PMID: 21774029
7. Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription Drug Use in Pregnancy: A Retrospective, Population-Based Study in British Columbia, Canada (2001-2006). Clin Ther. 2011.
8. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden-assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011; 3:43-50. doi: 10.2147/CLEP.S16305 PMID: 21386973
9. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011; 205 (1):51.e1-e8. doi: 10.1016/j.ajog.2011.02.029 PMID: 21514558
10. Bjorn AM, Norgaard M, Hundborg HH, Nohr EA, Ehrenstein V. Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark. Clin Epidemiol. 2011; 3:149-56. Epub 2011/05/25. doi: 10.2147/CLEP.S17747 clep-3-149 [pii]. PMID: 21607016; PubMed Central PMCID: PMC3096515.
11. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol. 2008; 65(5):653-60. doi: 10.1111/j.1365-2125.2008.03102.x PMID: 18294334
12. Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription drugs during pregnancy and lactation - a Finnish register-based study. Eur J Clin Pharmacol. 2003; 59(2):127-33. PMID: 12700878
13. Lacroix I, Hurault C, Sarramon M, Guitard C, Berrebi A, Grau M, et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol. 2009; 65(8):839-46. doi: 10.1007/s00228-009-0647-2 PMID: 19365629
14. Gagne JJ, Maio V, Berghella V, Louis DZ, Gonnella JS. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol. 2008; 64(11):1125-32. doi: 10.1007/s00228-008-0546-y PMID: 18685836
15. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf. 2011; 20(2):177-84. doi: 10.1002/pds.2082 PMID: 21254289
16. Kessler R, Adler L, Barkley R, Biederman J, Conners C, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4):716-23. PMID: 16585449
17. Swanson LM, Pickett SM, Flynn H, Armitage R. Relationships among depression, anxiety, and insomnia symptoms in perinatal women seeking mental health treatment. J Womens Health. 2011; 20 (4):553-8.
18. Joseph K, Fahey J, Dendukuri N, Allen V, O'Campo P, Dodds L, et al. Recent changes in maternal characteristics by socioeconomic status. JOGC. 2009; 31(5):422-33. PMID: 19604423
19. Discharge Abstracts Database (Hospital Separations); Medical Services Plan (MSP) Payment Information File (Physician Billings); Consolidation File (MSP Registration and Premium Billing); PharmaNet (Prescriptions database). In: British Columbia Ministry of Health, editor. 2013.
20. Perinatal Services Births & Stillbirths. In: Perinatal Services BC, editor. 2012.
21. Vital Statistics Deaths. In: British Columbia Vital Statistics Agency, editor. 2012.
22. Hanley GE, Morgan S. On the validity of area-based income measures to proxy household income. BMC Health Serv Res. 2008; 8(1):79.
23. Hanley GE, Morgan S, Reid RJ. Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada. Med Care. 2010; 48 (5):402-8. doi: 10.1097/MLR.0b013e3181ca3d5d PMID: 20393369
24. World Health Organization. Anatomical Therapeutic Classification: Structure and Principles [Internet]. Oslo: World Health Organization; 2011 [updated 2011 Mar 25; cited 2014]. Anatomical Therapeutic Classification: Structure and Principles. Available from: http://www.whocc.no/atc/structure-and-principles/.
25. Health Canada. Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy [Internet]. Ottawa: Health Canada; 2005 [updated 2005 Dec 16; cited 2014]. Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy. Available from: http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14359a-eng.php.
26. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006; 63(8):898-906. PMID: 16894066
27. Bérard A, Sheehy O. The Quebec pregnancy cohort-prevalence of medication use during gestation and pregnancy outcomes. PLoS One. 2014; 9(4):e93870. doi: 10.1371/journal.pone.0093870 PMID: 24705674
28. Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM. Drugs Dispensed in Primary Care During Pregnancy. Drug Saf. 2010; 33(7):593-604. doi: 10.2165/11532330-000000000-00000 PMID: 20553060
29. Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, Jong-Van Den Berg D. Maternal medicine: Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006; 113(5):559-68. PMID: 16637899
30. Olesen C, Steffensen FH, Nielsen GL, Jong-van den Berg L, Olsen J, Sørensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol. 1999; 55(2):139-44. PMID: 10335909
31. Colvin L, Slack-Smith L, Stanley FJ, Bower C. Pharmacovigilance in pregnancy using populationbased linked datasets. Pharmacoepidemiol Drug Saf. 2009; 18(3):211-25. doi: 10.1002/pds.1705 PMID: 19173342
32. Schirm E, Meijer WM, Tobi H, de Jong-van den Berg LT. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol. 2004; 114(2):182-8. PMID: 15140513
33. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004; 191(2):398-407. PMID: 15343213
34. Egen-Lappe V, Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol. 2004; 60(9):659-66. PMID: 15480609
35. Administration; UFaD. Public Health Advisory: Use of Codeine By Some Breastfeeding Mothers May Lead To Life-Threatening Side Effects In Nursing Babies 2007. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm054717.htm.
36. Canada; H. Use of Codeine Products by Nursing Mothers 2008. Available from: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/13255a-eng.php.
37. Persaud N, Chin J, Walker M. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy? JOGC. 2014; 36(4):343-8. PMID: 24798673
38. Arsenault M, Lane C, MacKinnon C, Bartellas E, Cargill Y, Klein M, et al. The management of nausea and vomiting of pregnancy. JOGC. 2002; 24(10):817-31; quiz 32-3. PMID: 12405123
39. Koren G, Clark S, Hankins GD, Caritis SN, Miodovnik M, Umans JG, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol. 2010; 203(6):571. e1-. e7. doi: 10.1016/j.ajog.2010.07.030 PMID: 20843504
40. Food U, Administration D. Determination that Bendectin was not withdrawn for sale for reasons of safety or effectiveness. Fed Regist. 1999; 64:43190-1.
41. Chin JW, Gregor S, Persaud N. Re-analysis of safety data supporting doxylamine use for nausea and vomiting of pregnancy. Am J Perinatol. 2013;(EFirst).
42. Yang T, Walker MC, Krewski D, Yang Q, Nimrod C, Garner P, et al. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiol Drug Saf. 2008; 17(3):270-7. doi: 10.1002/pds.1538 PMID: 18181228
43. Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010; 19(4):408-17. doi: 10.1002/pds.1906 PMID: 20099251
44. Riley EH, Fuentes-Afflick E, Jackson RA, Escobar GJ, Brawarsky P, Schreiber M, et al. Correlates of prescription drug use during pregnancy. J Womens Health. 2005; 14(5):401-9.
45. Lupattelli A, Spigset O, Twigg M, Zagorodnikova K, Mårdby A-C, Moretti M, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014; 4(2):e004365. doi: 10. 1136/bmjopen-2013-004365 PMID: 24534260
46. Tamblyn R, Eguale T, Huang A, Winslade N, Doran P. The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study. Ann Intern Med. 2014; 160 (7):441-50. doi: 10.7326/M13-1705 PMID: 24687067
47. Nakhai-Pour HR, Broy P, Bérard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. Can Med Assoc J. 2010; 182(10):1031-7.
48. Olesen C, Thrane N, Henriksen TB, Ehrenstein V, Olsen J. Associations between socio-economic factors and the use of prescription medication during pregnancy. Eur J Clin Pharmacol. 2006; 62(7):547-53. PMID: 16673101